Company news

Actinogen Medical Limited news in 2016

Actinogen Medical Limited's news releases, calls and decks from 2016, newest first.

View company

Closure of laboratory

February 10, 2016

Clinical Trial Update-Xanamem Drug for Alzheimers Dementia

February 10, 2016

Clinical Trial Successfully Completed with Xanamem

February 10, 2016

Capital Raising

February 10, 2016

Biofuel program update

February 10, 2016

Bio-ethanol Commercialisation Strategy

February 10, 2016

Appendix 4D Half Yearly Report and Accounts

February 10, 2016

Appendix 4D and Half Yearly Accounts

February 10, 2016

Appendix 4D and Half Year Accounts

February 10, 2016

Appendix 4C

February 10, 2016

ACW: LER to Fund 1st Trial on Actingoen's Bioethanol Project

February 10, 2016

Activity Report & Appendix 4C

February 10, 2016

Actinogen to receive further funding from Otsana Capital

February 10, 2016

Actinogen to acquire Corticrine Limited

February 10, 2016

Actinogen scales up Anacardic Acid production

February 10, 2016

Actinogen New Discovery in the Biofuel Research Program

February 10, 2016

Actinogen Medical Appoints Dr Bill Ketelbey as CEO

February 10, 2016

Actinogen Isolates Demonstrate Antitumorigenic Activity

February 10, 2016

Actinogen Board Changes

February 10, 2016

Actinogen & Curtin Uni to Work on Cancer Stem Cells

February 10, 2016

← Newer news releases

Decks in 2016